Navigation Links
TPI to Host Third Quarter of Fiscal Year 2012 Earnings Conference Call on Tuesday, May 15, 2012 at 9:00 a.m. ET
Date:5/3/2012

CHENGDU, China, May 3, 2012 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the third quarter of fiscal year 2012 ending March 31, 2012 is to be held at 9:00 a.m. ET on Tuesday, May 15, 2012.

Interested parties may access the call by dialing +1-877-941-1428 (U.S.), 1-480-629-9665 (International)

The conference ID is 4537560. It is advisable to dial in approximately 5 minutes prior to the start of the call.

A replay will be available by calling +1-877-870-5176 (U.S.), 1-858-384-5517 (International), from 5/15/2012 at 12:00 noon ET till 5/29/2012 at 11:59 pm ET,

Replay Pin Number:  4537560

This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at the following link: http://viavid.net/dce.aspx?sid=00009773

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list (EDL) of China. TPI's pipeline targets various high incidence healthcare indications. For more information about TPI, please visit:  http://www.tianyinpharma.com.

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit: http://www.tianyinpharma.com, or email: ir@tpi.asia

Tel: +86-28-8551-6696 (Chengdu, China)
      +86-134-3655-0011 (China)

Address:
Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza     
No. 2, Block 3, South Renmin Road
Chengdu, 610041
China


'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health Reports Third-Quarter Results
2. Hill-Rom Announces Third Quarter 2012 Dividend
3. Cardica Announces Fiscal 2012 Third Quarter Financial Results
4. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
5. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
6. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
7. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
8. Unilife Corporation to Announce Financial Results for Fiscal 2012 Third Quarter on Thursday, April 26, 2012
9. PAREXEL Announces Date of Third Quarter Fiscal Year 2012 Earnings Release and Conference Call
10. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
11. Biosensors Reports Continued Strong Sales and Earnings Growth in the Third Quarter of Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016  While you may be familiar with watching a film or TV show ... as ultra-high-definition or 8MP in the Medical Industry.  Ampronix  is a renowned authorized reseller of ... Photo - http://photos.prnewswire.com/prnh/20160502/362730 ... ... ...
(Date:5/3/2016)... DUBLIN , May 3, 2016 ... to pay $55 million to a woman who says ... State court awarded Gloria Ristesund $5 million ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... of accusations against the company. In February, the same ...
(Date:5/3/2016)... May 3, 2016 Intec Pharma ... clinical-stage biopharmaceutical company, today announced the appointment of ... Affairs. "Ms. Strauss-Levy has 15 years of ... established an outstanding track record, having supported the advancement ... approval processes in the United States ...
Breaking Medicine Technology:
(Date:5/3/2016)... ON (PRWEB) , ... May 03, 2016 , ... ... recognized as one of Canada’s top Information and Communication Technology (ICT) companies in ... Canadian and Multinational ICT companies operating in Canada, as ranked by revenue. ...
(Date:5/3/2016)... CA (PRWEB) , ... May 03, 2016 , ... ... a special type of surgical procedure that can be used to diagnose and treat ... instruments can be inserted. These instruments include a special lighting system and lens that ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... connectivity solutions, today announced the new SecureAccess feature for its CelestixEdge solution. ... SecureAccess release will enable organizations to get the DirectAccess user experience on ...
(Date:5/3/2016)... ... ... LunchSkins is changing the future of ocean plastic pollution by launching ... baggies. The mission-driven bags give back to global leaders in the fight to end ... is all about reducing global plastic waste and we’ve teamed up with some powerful ...
(Date:5/3/2016)... (PRWEB) , ... May 03, ... ... Carnival Cruise Lines premiered the state-of-the-art Carnival Vista – the line’s largest ... ship, The Cruise Web has created an infographic spotlighting the Carnival ...
Breaking Medicine News(10 mins):